Shanghai Electric showcases embodied intelligence robot matrix and AI-native smart factory solutions at WAIC 2026

Featuring humanoid robots with 41 degrees of freedom, pipe‑inspection robots with ±1mm positioning accuracy, and 51 industrial‑grade AI agentsSHANGHAI, July 24, 2026 /PRNewswire/ -- Operations in high-end equipment manufacturing often involve confined spaces, complex objects, and fine manipulation…

Continue ReadingShanghai Electric showcases embodied intelligence robot matrix and AI-native smart factory solutions at WAIC 2026

PRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records

SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating a data breachthat led to unauthorized access to the sensitive information of patients affiliated with Abbott Laboratories ("Abbott"), an Illinois-based healthcare and medical device…

Continue ReadingPRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records

MaxsMaking Inc. Announces Receipt of Nasdaq Delisting Determination Notice

  • Post author:
  • Post category:Business

SHANGHAI, July 23, 2026 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, today announced that it received a Staff Delisting Determination (the…

Continue ReadingMaxsMaking Inc. Announces Receipt of Nasdaq Delisting Determination Notice

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

  • Post author:
  • Post category:Sales & Growth

PALMA DE MALLORCA, Spain, July 23, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV)…

Continue ReadingLaminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

Save Remote Monitoring Coalition Launches to Oppose Flawed CMS Proposals in the 2027 Physician Fee Schedule

Providers and remote monitoring companies unite to defend a proven Medicare benefit and to demand real enforcement against bad actors in place of structural cuts that would reduce access for patients.GREENVILLE, S.C., July 23, 2026 /PRNewswire/ -- ChartSpan…

Continue ReadingSave Remote Monitoring Coalition Launches to Oppose Flawed CMS Proposals in the 2027 Physician Fee Schedule